Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands

© 2013 by Lippincott Williams & Wilkins. Background: Lopinavir/ritonavir (LPV/r) pediatric tablets (100/25 mg) are approved by the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) as part of combination antiretroviral therapy. Dosing is based on body weight...

Full description

Saved in:
Bibliographic Details
Main Authors: Diane E.T. Bastiaans, Silvia Forcat, Hermione Lyall, Tim R. Cressey, Rawiwan Hansudewechakul, Suparat Kanjanavanit, Antoni Noguera-Julian, Christoph Konigs, Jamie R.J. Inshaw, Suwalai Chalermpantmetagul, Yacine Saidi, Alexandra Compagnucci, Lynda M. Harper, Carlo Giaquinto, Angela P.H. Colbers, David M. Burger
Format: Journal
Published: 2018
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84890378736&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/45156
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University